TickerFacts.

Company research / UNH

UnitedHealth Group Inc (UNH)

Build a valuation ↗↓ Download CSV

SEC name UNITEDHEALTH GROUP INC · CIK 0000731766 · NYSE · Hospital & Medical Service Plans

  • Sector Finance & Real Estate
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, UnitedHealth Group Inc reported revenue of $447.57B. Revenue grew 11.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $450.13B.

Key ratios (year ended 2025-12-31)

4.2%
Operating margin
2.7%
Net margin
12.0%
Return on year-end equity
11.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-13

Headquarters locality: Minnetonka · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$450.13B$447.57B$400.28B$371.62B$324.16B$287.60B$257.14B$242.16B$226.25B$201.16B$184.84B
Cost of Revenue$51.44B$50.66B$46.69B$38.77B$33.70B$31.03B$30.75B$28.12B$27.00B$24.11B$24.42B
Operating Income$21.68B$18.96B$32.29B$32.36B$28.43B$23.97B$22.41B$19.68B$17.34B$15.21B$12.93B
Depreciation & Amortization$4.29B$4.36B$4.10B$3.97B$3.40B$3.10B$2.89B$2.72B$2.43B$2.25B$2.06B
EBITDA$25.96B$23.32B$36.39B$36.33B$31.84B$27.07B$25.30B$22.41B$19.77B$17.45B$14.98B
Net Income$14.12B$12.06B$14.40B$22.38B$20.12B$17.29B$15.40B$13.84B$11.99B$10.56B$7.02B
EPS (Diluted)n/a$13.23$15.51$23.86$21.18$18.08$16.03$14.33$12.19$10.72$7.25
Total Assets$309.73B$309.58B$298.28B$273.72B$245.71B$212.21B$197.29B$173.89B$152.22B$139.06B$122.81B
Total Liabilities$203.78B$207.88B$195.69B$174.80B$159.36B$135.73B$126.75B$111.73B$95.99B$87.04B$82.62B
Shareholders' Equity$104.51B$100.09B$98.27B$94.42B$81.45B$75.05B$68.33B$60.44B$54.32B$49.83B$38.18B
Cash & Equivalents$28.59B$24.36B$25.31B$25.43B$23.36B$21.38B$16.92B$10.98B$10.87B$11.98B$10.43B
Operating Cash Flow$27.02B$19.70B$24.20B$29.07B$26.21B$22.34B$22.17B$18.46B$15.71B$13.60B$9.79B
Capital Expenditures$3.40B$3.62B$3.50B$3.39B$2.80B$2.45B$2.05B$2.07B$2.06B$2.02B$1.71B
Free Cash Flow$23.62B$16.07B$20.70B$25.68B$23.40B$19.89B$20.12B$16.39B$13.65B$11.57B$8.09B
Share Repurchases$1.65B$5.54B$9.00B$8.00B$7.00B$5.00B$4.25B$5.50B$4.50B$1.50B$1.28B
Dividends Paid$8.10B$7.92B$7.53B$6.76B$5.99B$5.28B$4.58B$3.93B$3.32B$2.77B$2.26B
Shares Outstanding905.00M906.00M915.00M924.00M934.00M941.00M946.00M948.00M960.00M969.00M952.00M
Dividends Per Sharen/a$8.73$8.18$7.29$6.40$5.60$4.83$4.14$3.45$2.88$2.38
Weighted Average Diluted Sharesn/a911.00M929.00M938.00M950.00M956.00M961.00M966.00M983.00M985.00M968.00M
EPS (Basic)n/a$13.28$15.64$24.12$21.47$18.33$16.23$14.55$12.45$10.95$7.37

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView